Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…
A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.
PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…
Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…
Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…
The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…
AI in neurosurgery market to grow from USD 850 million in 2025 to USD 11.3 billion by 2035 (29.5% CAGR). Growth drivers, key players and regional outlook.
AI-assisted surgery market to reach USD 39.31 billion by 2035 at 26.8% CAGR. Key growth trends, leading companies and how regions compare, led by North America.
A boiler explosion at the TIL Healthcare plant in Sri City, Andhra Pradesh on 3 October left several workers dead and injured; cause under investigation.
Maharashtra FDA cancelled the drug sale and distribution licences of Cipla Pune Wadki warehouse on 1 October over alleged lapses. Cipla calls it disappointing.
FDA extended its denecimig review as manufacturing-site remediation continues. No efficacy or safety issues were cited; Novo now expects a US launch in H1 2027.
Pennsylvania measles outbreak reached 977 confirmed cases in 39 counties as of 2 October, with 195 hospitalised and five deaths; MMR doses have surged.
Bayer will invest $2.2 billion in a New Albany, Ohio pharmaceutical campus with about 600 permanent jobs; the first module is due by 2031.
Datroway ivonescimab trials will start with a Phase III in first-line triple-negative breast cancer in a new AstraZeneca, Daiichi Sankyo and Summit pact.
Novartis Abogen deal: Abogen gets $575 million upfront and up to $7.2 billion in milestones for ABO2203, an mRNA T-cell engager for autoimmune disease.
PRIP scheme: India approved about ₹1,600 crore for 41 pharma and MedTech R&D projects, expected to draw ₹3,020 crore more in private investment.